ライフサイエンスコーパス: inclusion criteria

1 ber states (47 countries had no data meeting inclusion criteria).

2 tes for 130 distinct populations matched the inclusion criteria.

3 In total, 1,710 samples met inclusion criteria.

4 vational; total 13,737 participants) met the inclusion criteria.

5 RT during the study period, 84 met all study inclusion criteria.

6 133 eyes of 130 consecutive patients meeting inclusion criteria.

7 esized data from full-text articles that met inclusion criteria.

8 ge 32.5 +/- 10.7 years, 72.2% males) met the inclusion criteria.

9 Fourteen pediatric patients met inclusion criteria.

10 onized patients were identified: 513 met the inclusion criteria.

11 ted in 88 (38.6%) of the 228 studies meeting inclusion criteria.

12 randomized clinical trials (N = 44 521) met inclusion criteria.

13 In total, 778 patients met the inclusion criteria.

14 ia EUS or MRCP and seventy-four patients met inclusion criteria.

15 A total of 439 patients met the inclusion criteria.

16 * AND adolescen* OR student*; 29 studies met inclusion criteria.

17 italised during the study period and met the inclusion criteria.

18 venteen randomized controlled trials met the inclusion criteria.

19 Ninety procedures (87 eyes) met inclusion criteria.

20 There were 89 individuals that met inclusion criteria.

21 d in the analysis after applying pre-defined inclusion criteria.

22 ting that eyes with CST >= 400 um is another inclusion criteria.

23 Twenty-nine trials (N = 18 353) met inclusion criteria.

24 ias, and extracted data; 111 studies met the inclusion criteria.

25 Eight studies fulfilled the inclusion criteria.

26 ase III randomized controlled trials met the inclusion criteria.

27 ied as low-income and middle-income) met the inclusion criteria.

28 Among 2,084 patients, 1,289 met the inclusion criteria.

29 y relevant articles, out of which 32 met our inclusion criteria.

30 th a total of 3,377,318 individuals, met our inclusion criteria.

31 Finally, twenty studies met the inclusion criteria.

32 8 publications (1285 children) fulfilled the inclusion criteria.

33 action, 30+/-10%) had both VT and VF and met inclusion criteria.

34 omprising 108 664 participants, that met the inclusion criteria.

35 Of the 2088 studies retrieved, 32 met our inclusion criteria.

36 565 search results, 2107 manuscripts met the inclusion criteria.

37 icles screened, 7 studies (564 eyes) met our inclusion criteria.

38 following descendancy search; 3 of these met inclusion criteria.

39 A total of 107 patients met inclusion criteria.

40 s' websites for documents meeting predefined inclusion criteria.

41 me of interest because they did not meet the inclusion criteria.

42 ch 22 (representing 18 distinct studies) met inclusion criteria.

43 volving 2002 cases, 57.2% with dementia, met inclusion criteria.

44 s and 31 observational studies met the final inclusion criteria.

45 The search identified 30 studies meeting inclusion criteria.

46 ns during the study period, of which 455 met inclusion criteria.

47 e charts were analyzed, and 113 patients met inclusion criteria.

48 ch 725 articles were reviewed and 85 (N) met inclusion criteria.

49 orts comprising 28 544 individuals fulfilled inclusion criteria.

50 There were 146 transplants meeting the inclusion criteria.

51 From 56 721 records identified, 177 met inclusion criteria.

52 dentified 1928 articles, of which 37 met our inclusion criteria.

53 from January 1980 to July 2016 that met the inclusion criteria.

54 and 16 of the 696 articles reviewed met the inclusion criteria.

55 udies, all but one published since 2011, met inclusion criteria.

56 163 patients met inclusion criteria.

57 A total of 111 articles met our inclusion criteria.

58 1695 participants, of which 375 did not meet inclusion criteria.

59 udies were obtained and screened against the inclusion criteria.

60 Twelve studies met the inclusion criteria.

61 Of 2447 citations, 11 studies met our inclusion criteria.

62 Fifty studies (N = 323 279) met inclusion criteria.

63 Of 7368 screened studies, 74 met inclusion criteria.

64 Only 12 studies met inclusion criteria.

65 Fs from 13 156 eyes of 8499 patients met the inclusion criteria.

66 ligation (HL) or LL of IMA after meeting the inclusion criteria.

67 rary from 1966 to January 2017 following the inclusion criteria.

68 1980 to February 2017 that met predetermined inclusion criteria.

69 entified 203 articles of which seven met the inclusion criteria.

70 Of 2437 MR images identified, 603 fit the inclusion criteria.

71 Eighty-four eyes (55 patients) met the inclusion criteria.

72 tudies of multifaceted interventions met the inclusion criteria.

73 There were 22 958 patients who met inclusion criteria.

74 Overall, 847 participants met the study inclusion criteria.

75 v 7-8, 2018; of 1409 articles, seven met the inclusion criteria.

76 ed 115 patients, 25 of whom did not meet the inclusion criteria.

77 red paper between New Zealand and UK met the inclusion criteria.

78 lysis after application of our exclusion and inclusion criteria.

79 ana University between 1990 and 2016 who met inclusion criteria.

80 tudies and three systematic reviews) met the inclusion criteria.

81 8 articles identified, 24 ultimately met the inclusion criteria.

82 Forty-five patients met inclusion criteria.

83 Twenty-two Cochrane reviews met the inclusion criteria.

84 were assessed in full and 37 studies met the inclusion criteria.

85 678 patient-years of follow-up fulfilled our inclusion criteria.

86 rom 2850 screened articles, 26 fulfilled the inclusion criteria.

87 reviewed and a total of 208 patients met the inclusion criteria.

88 A total of 17 patients met the inclusion criteria.

89 Twenty-nine studies fulfilled our inclusion criteria.

90 records were reviewed, of which 151 met the inclusion criteria.

91 We included 18 128 patients who met the inclusion criteria.

92 llergic conditions other than asthma met the inclusion criteria.

93 patients were reviewed, and 12 patients met inclusion criteria.

94 articles published between 1939 and 2008 met inclusion criteria.

95 Nine patients met inclusion criteria.

96 0,596 unique articles, of which 403 RCTs met inclusion criteria.

97 nts underwent inguinal hernia repair and met inclusion criteria.

98 Twelve studies met inclusion criteria.

99 sults: Of the 2,136 responses, 1,111 met the inclusion criteria.

100 Sixty-eight studies met the inclusion criteria.

101 A total of 46 eyes from 28 patients met inclusion criteria.

102 usand nine-hundred seventy-four patients met inclusion criteria: 1,209 (61%) with no acute kidney inj

103 A total of 37,163 individuals met study inclusion criteria; 10.4% were tested by IGRA.

104 Of those, 1951 met the inclusion criteria: 1025/1951 (52.5%) never had coccidio

105 One hundred sixteen patients met the inclusion criteria; 105 evaluable patients with CNS-nega

106 l pool of 3,204 records, 152 studies met our inclusion criteria (11,815/11,528, 233/219, and 2,091/1,

107 Of 201 patients evaluated, 163 met inclusion criteria: 116 anomalous right CA (71%), 25 ano

108 348 patients receiving treatment for DME met inclusion criteria; 13 365 received macular laser, 9219

109 We retrieved 6,420 studies; 33 met the inclusion criteria, 14 of which were in patients with se

110 Twenty consecutive patients met the inclusion criteria: 17 had colorectal liver metastases,

111 Ninety-five articles from 47 studies met the inclusion criteria (18 kidneys, 7 livers, 11 hearts, 1 k

112 Twenty-eight of 1432 studies fulfilled inclusion criteria: 19 studies included all children wit

113 ed complete responses, of whom 874 met study inclusion criteria (190 attending physicians, 576 nurses

114 reports identified by the search, 28 met the inclusion criteria: 20 were cross-sectional and 8 were p

115 Thirty-two studies met the inclusion criteria, 27 in the lung, four in the skin and

116 A total of 212 trials met the inclusion criteria: 27 (13%) reported a significant redu

117 A total of 4 451 200 beneficiaries met inclusion criteria; 3 805 718 (85.5%) received eye care

118 In total, 407 patients met final inclusion criteria (332 adults, 75 children).

119 Of the 343 patients who met inclusion criteria, 333 completed genetic testing, and 8

120 Among 21787 surgical patients meeting inclusion criteria, 402 (1.8%) patients had preoperative

121 One hundred eight patients met inclusion criteria; 47% (n = 51) received an extended co

122 10 114 patients received ERM surgery and met inclusion criteria (5310 without ILM peel and 4804 with

123 ong 1,889,032 Medicare beneficiaries who met inclusion criteria 560,744 (n = 29.7%) individuals had a

124 dividuals screened (11/2016-7/2017), 200 met inclusion criteria; 58% injected drugs and 31% shared ne

125 with toric IOL implantation that met certain inclusion criteria, 80%, 84%, and 69% of eyes, respectiv

126 Of 60,349 citations, 407 articles met inclusion criteria; 87% were published after 2000.

127 Of the 1813 references, 15 met the inclusion criteria; 9 were randomized control trials.

128 Of 785,346 patients meeting inclusion criteria, 94,887 (12.1%) filled a preoperative

129 Four patients (2 in each arm) did not meet inclusion criteria after randomization, leaving 396 pati

130 Results Of 754 patients who met inclusion criteria (age, 8-18 years; mean age, 14.6 year

131 The inclusion criteria also required that patients had stabl

132 r burden meeting UNOS down-staging (UNOS-DS) inclusion criteria and (2) "all-comers" (AC-DS) with ini

133 xcluded (121 [13%] patients did not meet the inclusion criteria and 310 [32%] patients declined to pa

134 and 17 retrospective cohort studies) met the inclusion criteria and 56 were included in meta-analyses

135 heir concerns stem from disagreement on data inclusion criteria and analysis, misunderstanding of our

136 r 6 months, 17 healthy male participants met inclusion criteria and completed donations and psycholog

137 A total of 2005 men met inclusion criteria and completed the baseline and at lea

138 d retrieved articles for review according to inclusion criteria and extracted relevant information on

139 A total of 35 studies met inclusion criteria and form the evidence base, including

140 hase I and II studies of entrectinib met the inclusion criteria and inform the guideline update.

141 Desquilbet et al take issue with our data inclusion criteria and make several other dubious claims

142 Twenty-five studies met the inclusion criteria and provided data for focused questio

143 o their inclusion in the review according to inclusion criteria and quality assessment using the Stro

144 s with blinded end point evaluation that met inclusion criteria and were analyzed using fixed-effects

145 ected for a full-text review, and 13 met the inclusion criteria and were assigned a quality-of-eviden

146 After full-text reading, 28 articles met the inclusion criteria and were carried forward to data abst

147 esophagectomy between 1991 and 2017 who met inclusion criteria and were contactable, responded to th

148 Ninety-six eyes of 85 patients fit inclusion criteria and were enrolled between the 2 sites

149 s with acute neurologic symptoms, 73 met the inclusion criteria and were included (23.7%): thirty-fiv

150 Sixteen studies met inclusion criteria and were included in our study.

151 f 7401 publications screened, 34 studies met inclusion criteria and were included in the overall synt

152 cles initially retrieved, 15 studies met the inclusion criteria and were included in the review.

153 A total of twelve studies met the inclusion criteria and were included in the review.

154 Fourteen articles met the inclusion criteria and were included in this review.

155 A total of 17 studies fit the inclusion criteria and were included in this review: 16

156 f 7,300 unique citations, 22 studies met the inclusion criteria and were of sufficient quality, with

157 One hundred forty-one surgeons matched the inclusion criteria and were randomized in the PP (n = 65

158 3 patients were screened, of whom 64 met the inclusion criteria and were randomized to the AVF ligati

159 295 (51%) of 574 patients met all inclusion criteria and were randomly assigned to spirono

160 Of these, 67 met the inclusion criteria and were reviewed in depth.

161 ticles, 55 (n = 367,801 live births) met the inclusion criteria and were summarised narratively, 41 s

162 All patients met the same inclusion criteria and were treated following the same p

163 From a total of 882 reviews, 63 met the inclusion criteria, and 900 studies were identified.

164 rting on patellofemoral replacements met our inclusion criteria, and no case series reported 25 year

165 cipants who underwent randomization, met the inclusion criteria, and survived beyond the recruitment

166 826 citations identified, 22 met our overall inclusion criteria, and we included 9 in our primary met

167 oved Amazonian tree list; to discuss species inclusion criteria; and to highlight the ecological impo

168 , Ovid MEDLINE, and PubMed were searched and inclusion criteria applied.

169 In settings where inclusion criteria are assessed after imputation, the po

170 imal efficacy, patients that meet both these inclusion criteria are more likely to show benefit from

171 ths (r = - 0.27), suggesting that both these inclusion criteria are non-exclusive.

172 085 records identified, four studies met our inclusion criteria, assessing three SGLT2 inhibitors: em

173 ctively enrolled when they achieved the same inclusion criteria at an outpatient clinical encounter,

174 ched for patients fulfilling the following 3 inclusion criteria: BCR after radical prostatectomy (pT2

175 ess against SARS-CoV-2, including developing inclusion criteria, conducting the search, selecting art

176 Inclusion criteria consisted of unilateral cataract surg

177 Ten articles met the inclusion criteria, consisting of seven studies, with a

178 Six studies met the inclusion criteria, contributing a total of 187 patients

179 cal, imaging, interventional, and laboratory inclusion criteria could be analyzed, showing that the t

180 mbal stem cell deficiency complying with the inclusion criteria described in Methods.

181 Inclusion criteria: English language papers describing e

182 Studies meeting inclusion criteria focused on a guideline, protocol, or

183 Of the 632 screened studies, 6 studies met inclusion criteria for a total of 4950 participants unde

184 Nine PFAS met the inclusion criteria for analysis based on percent of valu

185 male CCSS participants, 5886 (51.9%) met all inclusion criteria for analysis.

186 f 769 patients (4.8%), respectively, met the inclusion criteria for hypothetical switching.

187 Inclusion criteria for meta-analysis were two or more st

188 se during the study period, 928 patients met inclusion criteria for our analysis.

189 ell-counts >= 500/ul, among them 178 met the inclusion criteria for the 10-year study.

190 Eleven studies met the inclusion criteria for the focused question 2.

191 fety analysis evaluated all patients meeting inclusion criteria for the occurrence of a thrombotic ev

192 We identified 89 studies that met our inclusion criteria for the systematic review, and 21 stu

193 Inclusion criteria for these two groups included age 18

194 gative breast cancer in the database met the inclusion criteria for this analysis.

195 Twenty articles met the inclusion criteria for this assessment and were assigned

196 ncy, of which 27 were deemed to have met the inclusion criteria for this assessment.

197 34 articles selected for full review met all inclusion criteria for this assessment.

198 Twenty-three subjects met the inclusion criteria for vancomycin-associated DRESS.

199 rom the study (16 [4%] patients did not meet inclusion criteria; four [1%] patients because of dosing

200 Fifty-seven studies met our inclusion criteria, giving an overall estimate of seropr

201 Patients who met inclusion criteria had frozen plasma samples tested for

202 Two authors selected papers according to inclusion criteria, identifying 16 cohort studies, 1 cas

203 f ensartinib with no major violations of the inclusion criteria (ie, the full analysis set).

204 tched case-control study (1:2) with the same inclusion criteria in children with LRTIs at three Dutch

205 ositive case patients; only 28% (n = 69) met inclusion criteria in the national case definition for s

206 a systematic search for survey datasets; the inclusion criteria in these searches were that the surve

207 Inclusion criteria included a Gynecologic Oncology Group

208 Inclusion criteria included adult patients with postoper

209 Inclusion criteria included an age of 12 years or older,

210 Inclusion criteria included cases exhibiting marginal gi

211 Inclusion criteria included completion of a food frequen

212 Inclusion criteria included iOCT after perfluorocarbon l

213 Inclusion criteria included iOCT after perfluorocarbon l

214 A total of 3334 recipients met inclusion criteria including 155 (5%) and 3179 (95%) who

215 Fifty-six gliomas met the inclusion criteria, including 19 oligodendrogliomas, 26

216 Seventeen studies met the inclusion criteria, including a total of 2,833 individua

217 e found 3012 references, of which 54 met the inclusion criteria initially.

218 We identified 41 studies that met our inclusion criteria involving 112,034 patients in total.

219 with 8 randomized controlled trials meeting inclusion criteria involving 526 patients.

220 Twenty-eight children met inclusion criteria (mean age 11.6 +/- 6.9 years): group

221 Of 128 enrolled, 100 participants met inclusion criteria (mean age, 48.6 years; 41 men).

222 alidated at a second hospital using the same inclusion criteria.Measurements and Main Results: A tota

223 Among the cohort of 123 RCTs that met inclusion criteria, median FI was 13 (interquartile rang

224 ty-nine of 41,301 studies identified met the inclusion criteria (n = 59 cohorts).

225 Of these, 391 eyes (73%) met the inclusion criteria of annual office visits and received

226 89 patients with advSM fulfilling the strict inclusion criteria of the D2201 study [ClinicalTrials.go

227 A total of 379 patients met inclusion criteria, of which 204 (54%) received PMRT whi

228 five eyes of 986 AREDS2 participants met the inclusion criteria; of these, 977 participants (99.1%) u

229 nty-two articles were identified; 41 met the inclusion criteria outlined for assessment and were sele

230 were selected and evaluated using selective inclusion criteria, phage criteria, and study characteri

231 Inclusion criteria provided a cohort of 39 patients.

232 A total of 53 patients met the inclusion criteria, receiving 26.4 +/- 15.9 intravitreal

233 based selection outperforms the conventional inclusion criteria, reducing by 20-25% the number of pat

234 series, and 11 pharmacokinetic studies) met inclusion criteria regarding the effect of extracorporea

235 Sixty six met inclusion criteria, reporting on 17,202 patients.

236 g the results from 102 studies fulfilled the inclusion criteria, representing 37 countries and all re

237 e included 12 articles meeting predetermined inclusion criteria: seven qualitative, two case studies,

238 A single study meeting inclusion criteria showed no association between EoE and

239 lated as the percentage of patients that met inclusion criteria that had a lift used for care.

240 ults: Among 1,117 patients with ARDS who met inclusion criteria, the median Crs was 30 (interquartile

241 Five surveys met our inclusion criteria: the Service Provision Assessment (SP

242 d screened, 35 were excluded for not meeting inclusion criteria, three declined to participate, and 2

243 After analysing 145/285 descriptors, meeting inclusion criteria, through randomised seven-fold cross-

244 We then developed our inclusion criteria to identify qualitative and quantitat

245 Cases meeting inclusion criteria underwent chart review and, when avai

246 Cases meeting inclusion criteria underwent medical records review and,

247 All recruited study subjects based on inclusions criteria underwent laboratory examination, tr

248 Conventional inclusion criteria used in osteoarthritis clinical trial

249 For 22 patients fulfilling the inclusion criteria, we ascribed the most likely etiology

250 Inclusion criteria were "definite thyroid storm," as def

251 Patients in the health system who met inclusion criteria were >=18 years old, had a body mass

252 Minimum inclusion criteria were >=4 visits within a 4-year windo

253 Major inclusion criteria were (1) having American Joint Commit

254 Inclusion criteria were (a) positive nasopharyngeal or l

255 Inclusion criteria were 1) data-based study; 2) age rang

256 Inclusion criteria were 18-50 years of age, use or willi

257 Inclusion criteria were a body-mass index greater than t

258 Key inclusion criteria were a randomized controlled trial th

259 Inclusion criteria were age >15 years of age with eviden

260 Inclusion criteria were age >18 years and a diagnosis of

261 Key inclusion criteria were age 1-4 years at the time of inf

262 Key inclusion criteria were age between 22 and 75 years, a d

263 No other restrictive inclusion criteria were applied.

264 Inclusion criteria were as follows: 1) adult patients (n

265 Key inclusion criteria were biopsy-proven NASH with Nonalcoh

266 To approximate real-world conditions, inclusion criteria were broad.

267 Inclusion criteria were CAD with >=50% stenosis (>=1 cor

268 Inclusion criteria were confirmed HIV infection and age

269 Inclusion criteria were declaration of death in the ED,

270 The seven studies meeting this study's inclusion criteria were done between Feb 22, 2013, and N

271 Inclusion criteria were emmetropic eyes, with a sphere b

272 Inclusion criteria were good general health, measured th

273 Fifty studies (N = 22 385) that met inclusion criteria were identified.

274 Inclusion criteria were less than 19 years at enrollment

275 The data of the women who met the inclusion criteria were linked to the data of their offs

276 Inclusion criteria were met by 41 patients.

277 PIONEER-HF inclusion criteria were met by 71 633 (71.8%) patients,

278 Inclusion criteria were microbiological positive AK case

279 Inclusion criteria were patients who underwent MMCR or E

280 Inclusion criteria were patients with primary orbital me

281 The inclusion criteria were PSMA PET performed for biochemic

282 Key inclusion criteria were severe symptomatic MR and high s

283 Inclusion criteria were short time interval (<30 days) b

284 Inclusion criteria were studies defining intrahepatic ch

285 Key inclusion criteria were the absence of high-risk multipl

286 Inclusion criteria were volume OCT scans of sufficient q

287 Inclusion criteria were: (1) more than 2 patients, (2) t

288 Inclusion criteria were: (1) patient underwent LPF at ou

289 Inclusion criteria were: a) PSMA-PET performed for bioch

290 Inclusion criteria were: age of 65-75 years, Mini-Mental

291 Inclusion criteria were: fish bone located beyond the es

292 24 studies met our inclusion criteria, which included 236 127 women living

293 study, 162 patients (7-18 years old) met our inclusion criteria with a mean age of 13.4 years at bone

294 r ejection fraction definitions, or stricter inclusion criteria with diastolic dysfunction or left ve

295 8 articles were screened and 78 articles met inclusion criteria with outcomes in surface contaminatio

296 articles identified, only 12 studies met the inclusion criteria, with 10 studies being eventually inc

297 irty men (81%) and seven women (19%) met the inclusion criteria, with a mean age of 61 years +/- 12 (

298 udies, with a total of 118,799 patients, met inclusion criteria, with a pooled estimate for surveilla

299 Results Thirty-seven studies met the inclusion criteria, with a total of 4224 participants an

300 Six cohorts met the inclusion criteria, with IPD on 23,038 participants.